Suppr超能文献

结核分枝杆菌三种PE/PPE家族蛋白中HLA-A*0201限制性细胞毒性T细胞表位

HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis.

作者信息

Chaitra M G, Shaila M S, Chandra N R, Nayak R

机构信息

Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India.

出版信息

Scand J Immunol. 2008 Apr;67(4):411-7. doi: 10.1111/j.1365-3083.2008.02078.x. Epub 2008 Feb 1.

Abstract

CD8+ T cells are thought to play an important role in protective immunity against tuberculosis. We report the identification of three peptides derived from Rv1818c, Rv3812 and Rv3018c proteins of Mycobacterium tuberculosis that bound to HLA-A0201 molecules and their ability to induce in vitro T-cell response in peripheral blood lymphocytes from HLA-A0201-positive healthy individuals (PPD+) and patients with TB. The peptide-specific cytotoxic T lymphocytes (CTL) generated were capable of recognizing peptide pulsed targets. Three 9-mer peptides bound with high affinity to HLA-A0201 and displayed low dissociation rates of the bound peptide from HLA. Epitope-specific recognition was demonstrated by the release of perforin and gamma-interferon. Overall, our results demonstrate the presence of HLA class I-restricted CD8+ CTL against proteins from PE and PPE proteins of M. tuberculosis and identify epitopes that are strongly recognized by HLA-A0201-restricted CD8+ T cells in humans. These epitopes thus represent potential subunit components for the design of vaccines against tuberculosis.

摘要

CD8 + T细胞被认为在抗结核保护性免疫中发挥重要作用。我们报告了从结核分枝杆菌的Rv1818c、Rv3812和Rv3018c蛋白中鉴定出三种与HLA - A0201分子结合的肽,以及它们在HLA - A0201阳性健康个体(PPD +)和结核病患者外周血淋巴细胞中诱导体外T细胞反应的能力。产生的肽特异性细胞毒性T淋巴细胞(CTL)能够识别肽脉冲靶标。三种9聚体肽与HLA - A0201具有高亲和力结合,并且结合的肽从HLA的解离率较低。穿孔素和γ干扰素的释放证明了表位特异性识别。总体而言,我们的结果证明了存在针对结核分枝杆菌PE和PPE蛋白的HLA I类限制性CD8 + CTL,并鉴定了在人类中被HLA - A0201限制性CD8 + T细胞强烈识别的表位。因此,这些表位代表了用于设计抗结核疫苗的潜在亚基成分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验